Clinical Trial Update: EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers [Phase 1, Phase 2]

View source ↗

Summary

EMB-01 is being studied in a Phase 1/2 trial for advanced or metastatic gastrointestinal cancers and is currently recruiting. The sponsor is Shanghai EpimAb Bio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Carcinoid Tumor
• Gastrointestinal Neuroendocrine Tumor

Drugs mentioned

• EMB-01

Snippet

Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. | Conditions: Neoplasms, Neoplasm Metastasis | Phase 1, Phase 2 | Status: RECRUITING